Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stine Bjørnsen"'
Autor:
Nina Haagenrud Schultz, Pål Andre Holme, Stine Bjørnsen, Carola Elisabeth Henriksson, Per Morten Sandset, Eva-Marie Jacobsen
Publikováno v:
Platelets, Vol 31, Iss 1, Pp 43-47 (2020)
Factor Xa inhibitors are safe and effective alternatives to warfarin, but several studies indicate that rivaroxaban may cause a different risk profile for bleeding. For instance, while the risk of major bleeding in general may be lower with rivaroxab
Externí odkaz:
https://doaj.org/article/06d2a660183045189d5073ccaf09412f
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abstract Background Emicizumab is a nonfactor replacement therapy for hemophilia A (HA) and is a bispecific monoclonal antibody mimicking factor VIII by binding both factors IXa and X. Although it reduces the frequency of bleeding episodes, there is
Externí odkaz:
https://doaj.org/article/79b73affbc374ae49b6af79c4ec9592d
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background Emicizumab is a nonfactor replacement therapy for hemophilia A (HA) and is a bispecific monoclonal antibody mimicking factor VIII by binding both factors IXa and X. Although it reduces the frequency of bleeding episodes, there is still nee
Autor:
Stine Bjørnsen, Per Morten Sandset, Nina Haagenrud Schultz, Carola E. Henriksson, Eva-Marie Jacobsen, Pål Andre Holme
Publikováno v:
Platelets. 31:43-47
Factor Xa inhibitors are safe and effective alternatives to warfarin, but several studies indicate that rivaroxaban may cause a different risk profile for bleeding. For instance, while the risk of major bleeding in general may be lower with rivaroxab
Autor:
Pål Andre Holme, Stine Bjørnsen, Nina Haagenrud Schultz, Carola E. Henriksson, Per Morten Sandset, Hoa T. T. Tran
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Essentials An antidote for apixaban is not yet available.We tested the effect of different haemostatic agents to reverse the apixaban effect in vitro.Activated prothrombin complex concentrate (aPCC) was superior to prothrombin complex concentrate and
Autor:
P. Andre Holme, B. Sørensen, H. T. T. Tran, Are Hugo Pripp, Geir E. Tjønnfjord, Stine Bjørnsen
Publikováno v:
Haemophilia. 21:275-283
The aim of this study was to evaluate the capability of thromboelastometry (ROTEM) and thrombin generation assay (TGA) to monitor the treatment response of bypassing agent (BPA) therapy and to study whether one method is superior to another. In a pro
Autor:
Stine Bjørnsen, Carola E. Henriksson, Per Morten Sandset, Hoa Thi Tuyet Tran, Pål Andre Holme, Nina Haagenrud Schultz
Publikováno v:
Thrombosis Journal
Background An increasing number of patients are treated with direct-acting oral anticoagulants (DOACs), but the optimal way to reverse the anticoagulant effect is not known. Specific antidotes are not available and prothrombin complex concentrate (PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db3da3dc137b54f0da58539e0edbaa3
http://hdl.handle.net/10852/53956
http://hdl.handle.net/10852/53956
Autor:
Frank Brosstad, Gunnar Sandbæk, Stine Bjørnsen, Turid M. Pedersen, Jørgen J. Jørgensen, Erik Krag Jenssen
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 72:23-28
The purpose of this study was to measure the in vivo platelet activation and thrombin generation in arterial blood after passing a subintimal conduit.Subintimal percutaneous transluminal angioplasty (SPTA) is a technique where a subintimal channel is
Autor:
Frank Brosstad, F. Müller, B Lunden, E. C. Ng, Kari Otterdal, P. Aukrust, Stine Bjørnsen, Stig S. Frøland, Thor Ueland, W. Ameln, Nils Olav Solum
Publikováno v:
Thrombosis and Haemostasis. 84:183-187
SummaryLevels of circulating von Willebrand factor (vWf) antigen are thought to reflect endothelial involvement in various disorders. In the present study we found markedly elevated plasma levels of vWf in HIV-infected patients demonstrated on both c
Autor:
Thor Ueland, Geir E. Tjønnfjord, B. Sørensen, Pål Andre Holme, Stine Bjørnsen, C. J. Rea, H. T. T. Tran, Are Hugo Pripp
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 20(3)
Haemophilia patients with inhibitors require bypassing agents (BPA) like activated prothrombin complex concentrate (aPCC) and recombinant activated factor VII (rFVIIa) to control bleeds. Adjunct tranexamic acid (TXA) may improve haemostasis. The obje